chr10-110781073-ATGC-A
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PM4_SupportingBS2
The NM_001134363.3(RBM20):c.468_470delTGC(p.Ala157del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00000644 in 1,551,742 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A156A) has been classified as Likely benign.
Frequency
Consequence
NM_001134363.3 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- dilated cardiomyopathy 1DDInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RBM20 | NM_001134363.3 | c.468_470delTGC | p.Ala157del | disruptive_inframe_deletion | Exon 2 of 14 | ENST00000369519.4 | NP_001127835.2 | |
| RBM20 | XM_017016103.3 | c.303_305delTGC | p.Ala102del | disruptive_inframe_deletion | Exon 2 of 14 | XP_016871592.1 | ||
| RBM20 | XM_017016104.3 | c.84_86delTGC | p.Ala29del | disruptive_inframe_deletion | Exon 2 of 14 | XP_016871593.1 | ||
| RBM20 | XM_047425116.1 | c.84_86delTGC | p.Ala29del | disruptive_inframe_deletion | Exon 2 of 14 | XP_047281072.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RBM20 | ENST00000369519.4 | c.468_470delTGC | p.Ala157del | disruptive_inframe_deletion | Exon 2 of 14 | 1 | NM_001134363.3 | ENSP00000358532.3 | ||
| RBM20 | ENST00000718239.1 | c.468_470delTGC | p.Ala157del | disruptive_inframe_deletion | Exon 2 of 14 | ENSP00000520684.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152186Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000572 AC: 8AN: 1399556Hom.: 0 AF XY: 0.00000290 AC XY: 2AN XY: 690274 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74332 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 1DD Uncertain:2
- -
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 518222). This variant has been observed in individual(s) with clinical features of RBM20-related conditions (PMID: 30847666). This variant is present in population databases (no rsID available, gnomAD 0.007%). This variant, c.468_470del, results in the deletion of 1 amino acid(s) of the RBM20 protein (p.Ala158del), but otherwise preserves the integrity of the reading frame. -
Cardiovascular phenotype Uncertain:1
The c.468_470delTGC variant (also known as p.A158del) is located in coding exon 2 of the RBM20 gene. This variant results from an in-frame TGC deletion at nucleotide positions 468 to 470. This variant was detected in a cardiomyopathy genetic testing cohort; however, clinical details were limited, and additional cardiac variants were detected in some cases (van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309). This results in the in-frame deletion of an alanine at codon 158. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at